Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus

BACKGROUND: The apolipoprotein B/A1 (apoB/A1) ratio is a stronger predictor of future cardiovascular disease than is the level of conventional lipids. Statin and ezetimibe combination therapy have shown additional cardioprotective effects over statin monotherapy. METHODS: This was a single-center, r...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Diabetes Metab J
Huvudupphovsmän: Hwang, You-Cheol, Jun, Ji Eun, Jeong, In-Kyung, Ahn, Kyu Jeung, Chung, Ho Yeon
Materialtyp: Artigo
Språk:Inglês
Publicerad: Korean Diabetes Association 2019
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6834829/
https://ncbi.nlm.nih.gov/pubmed/30688048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2018.0124
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk